Chemotherapy

SJR Rank #13,194H-index: 64SJR: 0.442Best quartile: Q3
Journal website: aims, scope and author guidelines
Publisher

S. Karger AG

Country

Switzerland

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Drug DiscoveryQ3
  • Infectious DiseasesQ3
  • Medicine (miscellaneous)Q3
  • OncologyQ3
  • PharmacologyQ3
  • Pharmacology (medical)Q3

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Legal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesAntibiotics Pharmacokinetics and EfficacyAntibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusDrug-Induced Adverse ReactionsPneumonia and Respiratory InfectionsBlood disorders and treatmentsUrinary Tract Infections Management

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0255075100

Documents per Year

2022202508162432

Detailed Information

ISSN

0009-3157, 1421-9794

SJR Best Quartile

Q3

Region

Western Europe

Citations per Document (2 years)

1.10

References per Document

39.14

Coverage

1960-2025

Scope

This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.

Metrics from SCImago Journal Rank 2025. View on SCImago